80 related articles for article (PubMed ID: 28296049)
1. Quantitative structure-activity relationship and molecular docking studies on designing inhibitors of the perforin.
Song F; Cui L; Piao J; Liang H; Si H; Duan Y; Zhai H
Chem Biol Drug Des; 2017 Oct; 90(4):535-544. PubMed ID: 28296049
[TBL] [Abstract][Full Text] [Related]
2. Dihydrofuro[3,4-c]pyridinones as inhibitors of the cytolytic effects of the pore-forming glycoprotein perforin.
Lena G; Trapani JA; Sutton VR; Ciccone A; Browne KA; Smyth MJ; Denny WA; Spicer JA
J Med Chem; 2008 Dec; 51(23):7614-24. PubMed ID: 19007200
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological evaluation and 3D-QSAR studies of imidazolidine-2,4-dione derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Wang MY; Jin YY; Wei HY; Zhang LS; Sun SX; Chen XB; Dong WL; Xu WR; Cheng XC; Wang RL
Eur J Med Chem; 2015 Oct; 103():91-104. PubMed ID: 26342135
[TBL] [Abstract][Full Text] [Related]
4. Exploration of a series of 5-arylidene-2-thioxoimidazolidin-4-ones as inhibitors of the cytolytic protein perforin.
Spicer JA; Lena G; Lyons DM; Huttunen KM; Miller CK; O'Connor PD; Bull M; Helsby N; Jamieson SM; Denny WA; Ciccone A; Browne KA; Lopez JA; Rudd-Schmidt J; Voskoboinik I; Trapani JA
J Med Chem; 2013 Dec; 56(23):9542-55. PubMed ID: 24195776
[TBL] [Abstract][Full Text] [Related]
5. In silico identification of novel IL-1β inhibitors to target protein-protein interfaces.
Halim SA; Jawad M; Ilyas M; Mir Z; Mirza AA; Husnain T
Comput Biol Chem; 2015 Oct; 58():158-66. PubMed ID: 26253030
[TBL] [Abstract][Full Text] [Related]
6. P56(lck) kinase inhibitor studies: a 3D QSAR approach towards designing new drugs from flavonoid derivatives.
Gunda SK; Narasimha SK; Shaik M
Int J Comput Biol Drug Des; 2014; 7(2-3):278-94. PubMed ID: 24878734
[TBL] [Abstract][Full Text] [Related]
7. Quantitative structure-activity relationship (QSAR) studies on a series of 1,3,4-thiadiazole-2-thione derivatives as tumor-associated carbonic anhydrase IX inhibitors.
Abdel-Hamid MK; Abdel-Hafez AA; El-Koussi NA; Mahfouz NM
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):722-9. PubMed ID: 18720193
[TBL] [Abstract][Full Text] [Related]
8. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholinesterase inhibitors: structure based design, synthesis, pharmacophore modeling, and virtual screening.
Valasani KR; Chaney MO; Day VW; Shidu Yan S
J Chem Inf Model; 2013 Aug; 53(8):2033-46. PubMed ID: 23777291
[TBL] [Abstract][Full Text] [Related]
10. In silico study combining docking and QSAR methods on a series of matrix metalloproteinase 13 inhibitors.
Xi L; Li S; Yao X; Wei Y; Li J; Liu H; Wu X
Arch Pharm (Weinheim); 2014 Nov; 347(11):825-33. PubMed ID: 25363411
[TBL] [Abstract][Full Text] [Related]
11. QSAR Study of Novel 1, 8-Naphthimide Derivatives Targeting Nuclear DNA.
Lian Z; Tai Y; Xia H; Zhai H
Anticancer Agents Med Chem; 2023; 23(6):726-733. PubMed ID: 36017845
[TBL] [Abstract][Full Text] [Related]
12. QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors.
Fatemi MH; Heidari A; Gharaghani S
J Theor Biol; 2015 Mar; 369():13-22. PubMed ID: 25600056
[TBL] [Abstract][Full Text] [Related]
13. Molecular modeling studies of pyridopurinone derivatives--potential phosphodiesterase 5 inhibitors.
Srivani P; Srinivas E; Raghu R; Sastry GN
J Mol Graph Model; 2007 Jul; 26(1):378-90. PubMed ID: 17307372
[TBL] [Abstract][Full Text] [Related]
14. Structure-based quantitative structure-activity relationship studies of checkpoint kinase 1 inhibitors.
Du J; Xi L; Lei B; Lu J; Li J; Liu H; Yao X
J Comput Chem; 2010 Nov; 31(15):2783-93. PubMed ID: 20839304
[TBL] [Abstract][Full Text] [Related]
15. Pharmacophore modeling, 3D-QSAR and docking study of 2-phenylpyrimidine analogues as selective PDE4B inhibitors.
Tripuraneni NS; Azam MA
J Theor Biol; 2016 Apr; 394():117-126. PubMed ID: 26804643
[TBL] [Abstract][Full Text] [Related]
16. Theoretical studies of QSAR and molecular design on a novel series of ethynyl-3-quinolinecarbonitriles as SRC inhibitors.
Fang DQ; Wu WJ; Zhang R; Zeng GH; Zheng KC
Chem Biol Drug Des; 2012 Jul; 80(1):134-47. PubMed ID: 22429605
[TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR and molecular docking study of LRRK2 kinase inhibitors by CoMFA and CoMSIA methods.
Pourbasheer E; Aalizadeh R
SAR QSAR Environ Res; 2016 May; 27(5):385-407. PubMed ID: 27228480
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling studies on benzimidazole carboxamide derivatives as PARP-1 inhibitors using 3D-QSAR and docking.
Zeng H; Zhang H; Jang F; Zhao L; Zhang J
Chem Biol Drug Des; 2011 Sep; 78(3):333-52. PubMed ID: 21585709
[TBL] [Abstract][Full Text] [Related]
19. Jak2 inhibitor--a jackpot for pharmaceutical industries: a comprehensive computational method in the discovery of new potent Jak2 inhibitors.
Singh KhD; Naveena Q; Karthikeyan M
Mol Biosyst; 2014 Aug; 10(8):2146-59. PubMed ID: 24874539
[TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors.
Gharaghani S; Khayamian T; Ebrahimi M
SAR QSAR Environ Res; 2013; 24(9):773-94. PubMed ID: 23863115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
